Difference between revisions of "CFLAR-AS1"

From LncRNAWiki
Jump to: navigation, search
(Expression)
(Function)
 
Line 5: Line 5:
  
 
===Function===
 
===Function===
[[
+
[[File:CFLAR-AS1 func.JPG|right|thumb|400px|'''Prognosis predicting ability of circulating lncRNA ''CFLAR-AS1'''''<ref name="ref1" />.]]
 
Circulating level of lncRNA CFLAR-AS1 is associate with poor post-surgery prognosis of ESCC patients.<ref name="ref1" />
 
Circulating level of lncRNA CFLAR-AS1 is associate with poor post-surgery prognosis of ESCC patients.<ref name="ref1" />
 +
 
===Expression===
 
===Expression===
 
[[File:CFLAR-AS1 exp.JPG|right|thumb|400px|'''Expression of ''CFLAR-AS1'''''<ref name="ref1" />.]]
 
[[File:CFLAR-AS1 exp.JPG|right|thumb|400px|'''Expression of ''CFLAR-AS1'''''<ref name="ref1" />.]]

Latest revision as of 15:05, 25 October 2017

Annotated Information

Name

CFLAR-AS1:CFLAR antisense RNA 1

Function

Prognosis predicting ability of circulating lncRNA CFLAR-AS1[1].

Circulating level of lncRNA CFLAR-AS1 is associate with poor post-surgery prognosis of ESCC patients.[1]

Expression

Expression of CFLAR-AS1[1].

The expression of CFLAR-AS1 is significant up-regulated in both ESCC(esophageal squamous cell carcinoma) patients and dysplasia patients comparing with the control group. In addition, The expression of CFLAR-AS1 is stable in plasma.[1]

Diseases

Esophageal squamous cell carcinoma[1]

Sequence

>NR_040030.1 Homo sapiens CFLAR antisense RNA 1 (CFLAR-AS1), long non-coding RNA

000001 CATGCATACA GCCCAGTCTA ACGTACAGGA TCAAAAAGAG ACCTTATTTC GGCTGGCAAT TACCTTACCC GCTTGTTCAT 000080
000081 TATCTGACTC CTGCACTCCT CCCAAGTGTT CAATGTTAAC CAGATGGCAA AGTTAACCAG ACAGAGGAAA TCCACATAAT 000160
000161 TACTCTAGAT GAAGCCCCCT AACTGCGGAT TAGAAGGAAA AGAGATGAAG GGTGCTGCAC TAATAATAAC AACCATTTTC 000240
000241 AACCAAGGCA GGATTCTGGG CCTAGAATCT TCAGTGACAA ATTACCAGGA GAGGAGGAGG GAAATGAAGA GCTGGAGGCC 000320
000321 TAGGGAGATG GTGTGAGGAG AGGAGACTGT GCCTTTCCAC TTCTTAATAA TTAATGTTCT CCTGCTGCTC TGAGTCTGCA 000400
000401 TCACCAGTGA TTCAGTTTGA GTCAGACATC CAACAACAAC TGAGCAAAAG AATCATCTCA GATCCAAGCA ATGGTGACGC 000480
000481 GCAGATAGAA GAGACTGAGG CCAACGACCA AAGCAAAGGA CAGCAGAACT GACTGACACA GCTCAGAAAA TATCCAAAGC 000560
000561 TCTGTATGCT CTGGAAAGGA AGACAAGAAA TGCTAAAGAC TCTGGATATT GCTCTGTTTC TATAAGGTCC CACCCATATA 000640
000641 CCATCTCTTC TTTTGGATTT CCTTTGGCAG GGTTCCCTTG TATGGAAGTT CTCAGGAGAA CAACACTCTC AGAGTCCCAC 000720
000721 TGTCTCAAAG AATTCTTAAT GGACAGCTAT ACTTGGCCCC AAGGTTTCAA CCTCACACTG AAGAAAGTGA CATAAGAAAA 000800
000801 CACAAGTCCC AGTGCTATCA GGGGCTATCT GGAAAAGCTG CTTAAACAGC AAGTGAAAGA AGGCTCTCCC CTACCCCGTT 000880
000881 CTAGACTCAC CCTGAAGTTA TTTGAAGGAT CCTTGAGACT CTTTTGGATT GCTGCTTGGA GAACATTCCT GTAACTTGTC 000960
000961 CCTGCTCCTT GAACTATAAA AGCAGAAGGG AGGTACTGAG TTAAAACTTA CAAATTATTA TCAAATAAAT CTTCAATAGT 001040
001041 G

Labs working on this lncRNA

  • Department of Cardiothoracic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.

References

  1. 1.0 1.1 1.2 1.3 1.4 Hu HB, Jie HY, Zheng XX. Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma. Cell Physiol Biochem. 2016;40(1-2):117-125.